Richard Brewer Insider Profile
4 Followers
Richard Brewer, Director at Oruka Therapeutics, holds 45.16K shares in Dendreon Corp (Ticker: DNDNQ), holds 83.49K shares in Oruka Therapeutics (Ticker: ORKA).
Richard Brewer's Trading History
| DNDNQDendreon Corp | Jan 04, 2012 | ― | Uninformative Buy | ― | ― | |
| ORKAOruka Therapeutics | Feb 05, 2009 | Director | Uninformative Buy | ― | $8.29M |
You May Also Like
Richard Brewer insider profile FAQ
What is the percentage of profitable transactions made by Richard Brewer?
The percentage of profitable transactions made by Richard Brewer is 33%.
What is the average return per transaction made by Richard Brewer?
The average return per transaction made by Richard Brewer is -48.00%.
What stocks does Richard Brewer hold?
Richard Brewer holds: ORKA, DNDNQ stocks.
What was Richard Brewer's most profitable transaction?
Richard Brewer’s most profitable transaction was an Informative Sell of DNDNQ stock on May 7, 2010. The return on the trade was 10.80%.
What is Richard Brewer's role in Oruka Therapeutics?
Richard Brewer's role in Oruka Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
